Business
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and other related neurodegenerative diseasesSANTA ANA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the appoin
About this update from Nkgen Biotech Inc.
[{"type":"image","alt":"NKGen Biotech, Inc.","displaySize":"","headline":null,"caption":"NKGen Biotech, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":88,"url":"https://media.zenfs.com/en/globenewswire.com/6148ed3e2e28e6c539be48d0406ad510"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XRU5Bz8FlnWhn7nRqZ2pow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/6148ed3e2e28e6c539be48d0406ad510","width":300,"height":88}},"lazy":false},{"type":"text","content":"Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and other related neurodegenerative diseases","length":192,"tagName":"p"},{"type":"text","content":"SANTA ANA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the appointment of Bruce L. Miller, M.D. to its Scientific Advisory Board. Dr. Miller is internationally recognized for his leadership in Alzheimer’s disease (“AD”), frontotemporal dementia (“FTD”), and other neurocognitive disorders, and brings extensive scientific and clinical expertise to the Company.","length":603,"tagName":"p"},{"type":"text","content":"Dr. Miller is the A.W. and Mary Margaret Clausen Distinguished Professor in Neurology at the University of California, San Francisco (“UCSF”) where he directs the Edward and Pearl Fein Memory and Aging Center and is the founding director of the Global Brain Health Institute. His career spans decades at the forefront of clinical care, research, and education in neurodegenerative disease, advancing understanding of the brain-behavior relationship, the genetic and molecular foundations of dementia, and precision-medicine approaches for tauopathies and FTD-related conditions.","length":578,"tagName":"p"},{"type":"text","content":"“We are honored to welcome Dr. Miller to our Scientific Advisory Board. His global leadership in neurodegeneration research and his long-standing contributions to the Alzheimer’s and FTD fields bring a level of expertise that will meaningfully inform our clinical and scientific priorities as we conti...